For research use only. Not for therapeutic Use.
AKT Kinase Inhibitor is an Akt kinase inhibitor with anti-tumor activity[1].
The effect of selective inhibition of Akt in proliferating cells expressing Trop-2 is studied. Akt inhibition, either by silencing or with specific drugs, induces a marked decrease in cell proliferation in cells expressing Trop-2, in a dose-dependent fashion[1].
Trop-2 expressing tumors subcutaneously injected in animal models show a striking reduction of growth following treatment with specific drugs that inhibit Akt activity. Therefore Akt has a central functional role in mediating the Trop-2-dependent growth stimulus[1].
Catalog Number | I005042 |
CAS Number | 842148-40-7 |
Synonyms | 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(3-aminopropoxy)-1-ethylimidazo[4,5-c]pyridin-4-yl]prop-2-yn-1-ol |
Molecular Formula | C16H19N7O3 |
Purity | ≥95% |
InChI | InChI=1S/C16H19N7O3/c1-2-23-14-11(25-8-4-6-17)9-19-10(5-3-7-24)12(14)20-16(23)13-15(18)22-26-21-13/h9,24H,2,4,6-8,17H2,1H3,(H2,18,22) |
InChIKey | LWLOLQIXHMFYND-UHFFFAOYSA-N |
SMILES | CCN1C2=C(C(=NC=C2OCCCN)C#CCO)N=C1C3=NON=C3N |
Reference | [1]. Saverio Alberti, et al. Use of trop-2 as predictive marker of response to anti-tumor therapy based on inhibitors of cd9, akt and molecules of the tetraspanin signalling network. WO2013171777A2. |